XENE holder plans sale of 10,000 shares

A holder of XENE common shares filed a notice of intention to sell 10,000 common shares through RBC Wealth Management, 1501 Ave.

Rhea-AI Filing Summary

A holder of XENE common shares filed a notice of intention to sell 10,000 common shares through RBC Wealth Management, 1501 Ave. McGill College, Suite 2150, Montreal, with the shares listed on NASDAQ. The proposed sale date is 08/11/2026.

The disclosure also lists past transactions in common shares: an Open Market Purchase of 15,000 shares on 08/11/2017, an Exercise of Options with the issuer for 5,144 shares on 05/14/2025, and another Exercise of Options for 3,500 shares on 05/12/2026, each settled in cash.

Key Figures

Planned sale amount: 10,000 common shares Open Market Purchase: 15,000 common shares Option exercise: 5,144 common shares +1 more

4 metrics

Planned sale amount 10,000 common shares Securities to be sold through RBC Wealth Management

Open Market Purchase 15,000 common shares Open Market Purchase on 08/11/2017

Option exercise 5,144 common shares Exercise of Options with issuer on 05/14/2025 for cash

Option exercise 3,500 common shares Exercise of Options with issuer on 05/12/2026 for cash

Key Terms

Common Shares, Open Market Purchase, Exercise of Options

3 terms

Common Shares financial

"Common Shares | RBC Wealth Management 1501 Ave. McGill College"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Open Market Purchase financial

"Common Shares | 08/11/2017 | Open Market Purchase | Open"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Exercise of Options financial

"Common Shares | 05/14/2025 | Exercise of Options | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is disclosed for XENE in this Form 144 filing?

The filing discloses a planned sale of 10,000 common shares of XENE. These shares are to be sold through RBC Wealth Management and are listed for trading on NASDAQ.

When is the proposed sale date for the 10,000 XENE shares?

The proposed sale date for the 10,000 common shares is 08/11/2026. This date reflects when the holder expects to begin selling the shares, subject to market conditions and applicable rules.

Which broker is handling the planned XENE share sale?

The planned sale of 10,000 XENE common shares is to be handled by RBC Wealth Management, located at 1501 Ave. McGill College, Suite 2150, Montreal, H3A 3M8, as indicated in the filing.

What prior equity transactions related to XENE are listed in the filing?

The filing lists an Open Market Purchase of 15,000 common shares on 08/11/2017, plus option exercises for 5,144 shares on 05/14/2025 and 3,500 shares on 05/12/2026, each for cash.

On which market are the XENE shares in this filing traded?

The common shares referenced in the filing are traded on NASDAQ. The proposed 10,000-share sale and the historical transactions all relate to NASDAQ-listed common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:32 PM Accepted by SEC EDGAR 08/13/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001643085
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Xenon Pharmaceuticals Inc.
SEC File Number	001-36687
Address of Issuer	3650 Gilmore Way Burnaby BRITISH COLUMBIA, CANADA V5G 4W8
Phone	(604)-484-3300
Name of Person for Whose Account the Securities are To Be Sold	STEVEN GANNON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	RBC Wealth Management 1501 Ave. McGill College Suite 2150 Montreal Z4 H3A 3M8	10000	640553	96840432	08/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	08/11/2017	Open Market Purchase	Open Market Purchase			15000	08/11/2017	Cash
Common Shares	05/14/2025	Exercise of Options	Issuer			5144	05/14/2025	Cash
Common Shares	05/12/2026	Exercise of Options	Issuer			3500	05/12/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Steve Gannon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)